The nuclear factor kappa‐B (NF‐κB) has been implicated in AD pathology because the NF‐κB binding sites are present in the promoter regions of genes involved in Aβ production and inflammation [54, 55]. This evidence concerns the gene NFKB1 and Alzheimer disease.